X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/passport-technologies-inc-announces-positive-interim-phase-i-results-of-zolmitriptan-transdermal-microporation-system-for-the-treatment-of-acute-migraine-302103063.html
https://www.prnewswire.com/news-releases/passport-technologies-inc-initiated-us-phase-i-clinical-trial-of-zolmitriptan-transdermal-microporation-system-for-the-treatment-of-acute-migraine-302070038.html